Daniel Rehal

Recent news headlines have spotlighted how unethical and irresponsible behavior on the part of pharma companies and their agencies can breach public trust…

Advisory boards are a critical component to a successful pharma market–shaping strategy. They provide a window into the minds of top key opinion leaders (KOLs) to gain valuable insights on products, clinical studies, competition, or market dynamics. At the heart of a successful advisory board is a planning team that Read more…

As I was cleaning out some mail over this past Thanksgiving holiday, I had a hard time knowing what to do with a handful of handwritten cards. They were personal letters written to me this year from people who were offering their gratitude. They meant a lot to me. I Read more…

In my previous blog and article, I raised concerns about how a lack of compassion negatively impacts patient care. When patients perceive that they’re not being heard or their concerns are not taken seriously by their physicians, it can have deleterious effects on whether they’ll follow “doctor’s orders” for a Read more…

Imagine having a conversation with your future self, getting insights on avoiding pitfalls on your life’s journey. Philosophers have known for thousands of years why we need to live life forward yet with a strong need to understand our past. The new book, Your Future Self, by UCLA Professor Hal Read more…

Since Vision2Voice opened our doors in 2008, I’ve been both honored and humbled over these past 15 years. Looking back on my personal and professional growth as a business leader, as well as a colleague, mentor, and friend, I’ve learned many lessons along the way. Here are just a few: Read more…

While clinical excellence is the ultimate driver of positive outcomes, compassion can add significant value to those outcomes in measurable ways. What is compassion? Most scientists agree that compassion is the emotional response to another’s pain or suffering, involving an authentic desire to help. Compassion is included in the American Read more…

Pharmaceutical marketing has changed dramatically over the past two decades. The Office of Inspector General’s (OIG’s) Special Fraud Alert mandated tighter controls over peer-to-peer speaker programs. The Sunshine Act required greater transparency into monetary transactions between pharma manufacturers and healthcare providers (HCPs). Direct access to HCPs has declined steadily, with Read more…

Why do “snake oil” salespeople still exist within rare, but visible pockets of the BioPharma industry? People with questionable ethics have swindled patients, put people’s health at risk, and have garnered hundreds of millions of dollars in profits, only to leave many patients desperate, feeling ripped-off, and angry at an Read more…